These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 21831295)
1. Repression of human activation induced cytidine deaminase by miR-93 and miR-155. Borchert GM; Holton NW; Larson ED BMC Cancer; 2011 Aug; 11():347. PubMed ID: 21831295 [TBL] [Abstract][Full Text] [Related]
2. miR-29b directly targets activation-induced cytidine deaminase in human B cells and can limit its inappropriate expression in naïve B cells. Recaldin T; Hobson PS; Mann EH; Ramadani F; Cousins DJ; Lavender P; Fear DJ Mol Immunol; 2018 Sep; 101():419-428. PubMed ID: 30081328 [TBL] [Abstract][Full Text] [Related]
3. MicroRNAs miR-155 and miR-16 Decrease AID and E47 in B Cells from Elderly Individuals. Frasca D; Diaz A; Romero M; Ferracci F; Blomberg BB J Immunol; 2015 Sep; 195(5):2134-40. PubMed ID: 26223652 [TBL] [Abstract][Full Text] [Related]
4. Ago2 and a miRNA reduce Topoisomerase 1 for enhancing DNA cleavage in antibody diversification by activation-induced cytidine deaminase. Kobayashi M; Wakaguri H; Shimizu M; Higasa K; Matsuda F; Honjo T Proc Natl Acad Sci U S A; 2023 May; 120(18):e2216918120. PubMed ID: 37094168 [TBL] [Abstract][Full Text] [Related]
5. Oncogenic p95HER2 regulates Na+-HCO3- cotransporter NBCn1 mRNA stability in breast cancer cells via 3'UTR-dependent processes. Gorbatenko A; Olesen CW; Loebl N; Sigurdsson HH; Bianchi C; Pedraz-Cuesta E; Christiansen J; Pedersen SF Biochem J; 2016 Nov; 473(21):4027-4044. PubMed ID: 27609814 [TBL] [Abstract][Full Text] [Related]
8. Effects of ARHI on breast cancer cell biological behavior regulated by microRNA-221. Li Y; Liu M; Zhang Y; Han C; You J; Yang J; Cao C; Jiao S Tumour Biol; 2013 Dec; 34(6):3545-54. PubMed ID: 23801152 [TBL] [Abstract][Full Text] [Related]
9. ADAM12-L is a direct target of the miR-29 and miR-200 families in breast cancer. Duhachek-Muggy S; Zolkiewska A BMC Cancer; 2015 Mar; 15():93. PubMed ID: 25886595 [TBL] [Abstract][Full Text] [Related]
10. The 3'UTR of the pseudogene CYP4Z2P promotes tumor angiogenesis in breast cancer by acting as a ceRNA for CYP4Z1. Zheng L; Li X; Gu Y; Lv X; Xi T Breast Cancer Res Treat; 2015 Feb; 150(1):105-18. PubMed ID: 25701119 [TBL] [Abstract][Full Text] [Related]
11. Posttranscriptional upregulation of HER3 by HER2 mRNA induces trastuzumab resistance in breast cancer. Li X; Xu Y; Ding Y; Li C; Zhao H; Wang J; Meng S Mol Cancer; 2018 Aug; 17(1):113. PubMed ID: 30068375 [TBL] [Abstract][Full Text] [Related]
12. Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. Rivas MA; Venturutti L; Huang YW; Schillaci R; Huang TH; Elizalde PV Breast Cancer Res; 2012 May; 14(3):R77. PubMed ID: 22583478 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-16 modulates HuR regulation of cyclin E1 in breast cancer cells. Guo X; Connick MC; Vanderhoof J; Ishak MA; Hartley RS Int J Mol Sci; 2015 Mar; 16(4):7112-32. PubMed ID: 25830480 [TBL] [Abstract][Full Text] [Related]
14. Activation-induced cytidine deaminase (AID) is necessary for the epithelial-mesenchymal transition in mammary epithelial cells. Muñoz DP; Lee EL; Takayama S; Coppé JP; Heo SJ; Boffelli D; Di Noia JM; Martin DI Proc Natl Acad Sci U S A; 2013 Aug; 110(32):E2977-86. PubMed ID: 23882083 [TBL] [Abstract][Full Text] [Related]
15. Downregulated expression of miR-155, miR-17, and miR-181b, and upregulated expression of activation-induced cytidine deaminase and interferon-α in PBMCs from patients with SLE. Kaga H; Komatsuda A; Omokawa A; Ito M; Teshima K; Tagawa H; Sawada K; Wakui H Mod Rheumatol; 2015; 25(6):865-70. PubMed ID: 25775145 [TBL] [Abstract][Full Text] [Related]
16. Down regulation of miR200c promotes radiation-induced thymic lymphoma by targeting BMI1. Cui J; Cheng Y; Zhang P; Sun M; Gao F; Liu C; Cai J J Cell Biochem; 2014 Jun; 115(6):1033-42. PubMed ID: 24375660 [TBL] [Abstract][Full Text] [Related]
17. TIP60-miR-22 axis as a prognostic marker of breast cancer progression. Pandey AK; Zhang Y; Zhang S; Li Y; Tucker-Kellogg G; Yang H; Jha S Oncotarget; 2015 Dec; 6(38):41290-306. PubMed ID: 26512777 [TBL] [Abstract][Full Text] [Related]
18. Lipid raft-mediated miR-3908 inhibition of migration of breast cancer cell line MCF-7 by regulating the interactions between AdipoR1 and Flotillin-1. Li Y; Shan F; Chen J World J Surg Oncol; 2017 Mar; 15(1):69. PubMed ID: 28327197 [TBL] [Abstract][Full Text] [Related]
19. Primary mediastinal large B-cell lymphoma: transcriptional regulation by miR-92a through FOXP1 targeting. Romero M; Gapihan G; Castro-Vega LJ; Acevedo A; Wang L; Li ZW; El Bouchtaoui M; Di Benedetto M; Ratajczak P; Feugeas JP; Thieblemont C; Saavedra C; Janin A Oncotarget; 2017 Mar; 8(10):16243-16258. PubMed ID: 27806315 [TBL] [Abstract][Full Text] [Related]
20. MiR-107 suppresses proliferation of hepatoma cells through targeting HMGA2 mRNA 3'UTR. Wang Y; Chen F; Zhao M; Yang Z; Zhang S; Ye L; Gao H; Zhang X Biochem Biophys Res Commun; 2016 Nov; 480(3):455-460. PubMed ID: 27773820 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]